定义法尼醇X受体、乙型肝炎病毒X蛋白与肝细胞癌之间的关系:情况复杂
本文评述了乙型肝炎病毒X蛋白(HBx)与法尼醇X受体(FXR)及肝细胞癌(HCC)之间复杂的相互作用,指出全长或截短型HBx的反式激活可分别驱动或抑制HCC。所评论文通过体内外研究(含FXR敲除小鼠与HBx诱导小鼠杂交)描述了HBx-FXR相互作用系统,显示激活全长HBx可抑制HCC肿瘤生长。
要点
- HBx与FXR及HCC的关系复杂,全长或截短型HBx的反式激活可驱动或抑制HCC。
- 所评论文利用体内外研究(包括FXR敲除小鼠与HBx诱导小鼠杂交)描述HBx-FXR相互作用系统。
- 激活全长HBx可通过HBx-FXR相互作用抑制HCC肿瘤生长。
核心结论
- HBx与FXR的相互作用研究历来充满复杂性,本文为可能对开发HCC亟需疗法至关重要的这一关系提供了重要启示。
研究设计与样本
- 本文为评述文章,评述的原文研究采用体内和体外研究,包括将FXR敲除小鼠与HBx诱导小鼠杂交。
主要发现
- 所评论文描述了HBx-FXR相互作用系统,证明通过激活全长HBx可抑制HCC肿瘤生长。
- HBx与FXR及HCC的关系复杂,取决于全长或截短型HBx的反式激活,可驱动肿瘤发生或抑制HCC。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The relationship between hepatitis B virus X protein (HBx), farsenoid X receptor (FXR) and hepatocellular carcinoma (HCC) is a complicated one in that we have a viral protein interaction that can drive tumorigenesis or inhibit HCC depending upon transactivation of full-length or truncated HBx. In the current article the authors have elegantly described a system of HBx-FXR interaction that demonstrates inhibition of HCC tumor growth via activation of full-length HBx. The paper employs both in vivo and in vitro studies including using FXR knockout mice crossed with HBx induced mice. Overall, studies on the interaction between HBx and FXR have been riddled with complication and this paper sheds important light on the relationship that may be key in developing much needed therapies for HCC.
引用
- Kennedy L, Francis H. Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated. Hepatology. 2017. PMID: 27880978. doi:10.1002/hep.28959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。